The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey
Aim:Neuron-specific enolase (NSE) is a widely used tumor marker for the diagnosis of neuroendocrine tumors and small cell lung cancer (SCLC). This study aimed to evaluate the utilization, diagnostic rate, distribution by gender and age groups, and variation in test requests across different healthca...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2023-09-01
|
| Series: | Haseki Tıp Bülteni |
| Subjects: | |
| Online Access: |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-diagnostic-rate-and-clinical-mplications-of-ne/62233
|
| _version_ | 1827805602157428736 |
|---|---|
| author | Suayip Birinci Mustafa Mahir Ulgu |
| author_facet | Suayip Birinci Mustafa Mahir Ulgu |
| author_sort | Suayip Birinci |
| collection | DOAJ |
| description | Aim:Neuron-specific enolase (NSE) is a widely used tumor marker for the diagnosis of neuroendocrine tumors and small cell lung cancer (SCLC). This study aimed to evaluate the utilization, diagnostic rate, distribution by gender and age groups, and variation in test requests across different healthcare institutions for NSE.Methods:A cross-sectional analysis based on Data from the Ministry of Health of the Republic of Turkey data from 2017 to 2021 was conducted. Neuron-specific enolase tests were requested from a total of 24,763 individuals, and the results of 110,401 tests were evaluated.Results:Neuron-specific enolase has emerged as the most commonly requested tumor marker in pediatric hematology and oncology clinics. Compared to other tumor markers (cancer antigen 19-9, carcinoembryonic antigen, cancer antigen 15-3 etc.), NSE testing demonstrated the highest diagnostic rate. The test was predominantly requested prior to or simultaneously with the diagnosis and less frequently after the diagnosis. NSE testing showed a higher positivity rate in individuals with confirmed neuroendocrine tumors and SCLC than in others. Moreover, public, training, research, and university hospitals requested NSE tests more than other institutions.Conclusion:Neuron-specific enolase plays a significant role as a valuable tumor marker in the diagnosis of neuroendocrine tumors and SCLC. This study highlights the diagnostic rate, utilization in pediatric hematology and oncology clinics, and variations across healthcare institutions.. The findings of this study can guide clinicians and researchers in the management of these malignancies. |
| first_indexed | 2024-03-11T21:28:28Z |
| format | Article |
| id | doaj.art-1854879198e4412c8c6d7bf6111acf31 |
| institution | Directory Open Access Journal |
| issn | 1302-0072 2147-2688 |
| language | English |
| last_indexed | 2024-03-11T21:28:28Z |
| publishDate | 2023-09-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Haseki Tıp Bülteni |
| spelling | doaj.art-1854879198e4412c8c6d7bf6111acf312023-09-27T13:15:53ZengGalenos YayineviHaseki Tıp Bülteni1302-00722147-26882023-09-0161423123710.4274/haseki.galenos.2023.937513049054The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of TurkeySuayip Birinci0Mustafa Mahir Ulgu1 Deputy Minister, Ministry of Health, Ankara, Turkey Acting Director-General at Ministry of Health, Ankara, Turkey Aim:Neuron-specific enolase (NSE) is a widely used tumor marker for the diagnosis of neuroendocrine tumors and small cell lung cancer (SCLC). This study aimed to evaluate the utilization, diagnostic rate, distribution by gender and age groups, and variation in test requests across different healthcare institutions for NSE.Methods:A cross-sectional analysis based on Data from the Ministry of Health of the Republic of Turkey data from 2017 to 2021 was conducted. Neuron-specific enolase tests were requested from a total of 24,763 individuals, and the results of 110,401 tests were evaluated.Results:Neuron-specific enolase has emerged as the most commonly requested tumor marker in pediatric hematology and oncology clinics. Compared to other tumor markers (cancer antigen 19-9, carcinoembryonic antigen, cancer antigen 15-3 etc.), NSE testing demonstrated the highest diagnostic rate. The test was predominantly requested prior to or simultaneously with the diagnosis and less frequently after the diagnosis. NSE testing showed a higher positivity rate in individuals with confirmed neuroendocrine tumors and SCLC than in others. Moreover, public, training, research, and university hospitals requested NSE tests more than other institutions.Conclusion:Neuron-specific enolase plays a significant role as a valuable tumor marker in the diagnosis of neuroendocrine tumors and SCLC. This study highlights the diagnostic rate, utilization in pediatric hematology and oncology clinics, and variations across healthcare institutions.. The findings of this study can guide clinicians and researchers in the management of these malignancies. http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-diagnostic-rate-and-clinical-mplications-of-ne/62233 neuron-specific enolasebiomarkerstumor |
| spellingShingle | Suayip Birinci Mustafa Mahir Ulgu The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey Haseki Tıp Bülteni neuron-specific enolase biomarkers tumor |
| title | The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey |
| title_full | The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey |
| title_fullStr | The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey |
| title_full_unstemmed | The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey |
| title_short | The Diagnostic Rate and Clinical Implications of Neuron-Specific Enolase in Neuroendocrine Tumors and Small Cell Lung Cancer: Data from the Ministry of Health of the Republic of Turkey |
| title_sort | diagnostic rate and clinical implications of neuron specific enolase in neuroendocrine tumors and small cell lung cancer data from the ministry of health of the republic of turkey |
| topic | neuron-specific enolase biomarkers tumor |
| url |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-diagnostic-rate-and-clinical-mplications-of-ne/62233
|
| work_keys_str_mv | AT suayipbirinci thediagnosticrateandclinicalimplicationsofneuronspecificenolaseinneuroendocrinetumorsandsmallcelllungcancerdatafromtheministryofhealthoftherepublicofturkey AT mustafamahirulgu thediagnosticrateandclinicalimplicationsofneuronspecificenolaseinneuroendocrinetumorsandsmallcelllungcancerdatafromtheministryofhealthoftherepublicofturkey AT suayipbirinci diagnosticrateandclinicalimplicationsofneuronspecificenolaseinneuroendocrinetumorsandsmallcelllungcancerdatafromtheministryofhealthoftherepublicofturkey AT mustafamahirulgu diagnosticrateandclinicalimplicationsofneuronspecificenolaseinneuroendocrinetumorsandsmallcelllungcancerdatafromtheministryofhealthoftherepublicofturkey |